Treatment of Highly Drug-Resistant Pulmonary Tuberculosis. (2020)
Attributed to:
Tuberculosis Treatment Trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa1901814
PubMed Identifier: 32130813
Publication URI: http://europepmc.org/abstract/MED/32130813
Type: Journal Article/Review
Volume: 382
Parent Publication: The New England journal of medicine
Issue: 10
ISSN: 0028-4793